Expression of stem cell and mesenchymal markers in circulating tumor cells is associated with poor prognosis of early breast cancer patients
Nagel, A.; Markiewicz, A.; Szade, J.; Majewska, H.; Skokowski, J.; Seroczynska, B.; Welnicka-Jaskiewicz, M.; Zaczek, A.
Annals of Oncology: Official Journal of the European Society for Medical Oncology 28 Suppl. 7: Vii32
2017
ISSN/ISBN: 0923-7534
PMID: 31952755
DOI: 10.1093/annonc/mdx510.005
Accession: 069724138
PDF emailed within 0-6 h: $19.90
Related References
Krawczyk, N.; Meier-Stiegen, F.; Banys, M.; Neubauer, H.; Ruckhaeberle, E.; Fehm, T. 2014: Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients Biomed Research International 2014: 415721Kasimir-Bauer, S.; Hoffmann, O.; Wallwiener, D.; Kimmig, R.; Fehm, T. 2012: Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells Breast Cancer Research: Bcr 14(1): R15
Werner, S.; Stenzl, A.; Pantel, K.; Todenhöfer, T. 2017: Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells Advances in Experimental Medicine and Biology 994: 205-228
Liu, D.-G.; Xue, L.; Li, J.; Yang, Q.; Peng, J.-Z. 2018: Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer Cancer Biomarkers: Section a of Disease Markers 22(3): 417-426
Zhang, R.; Xia, J.; Wang, Y.; Cao, M.; Jin, D.; Xue, W.; Huang, Y.; Chen, H. 2020: Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients Oncotargets and Therapy 13: 10739-10748
Aktas, B.; Tewes, M.; Fehm, T.; Hauch, S.; Kimmig, R.; Kasimir-Bauer, S. 2009: Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Breast Cancer Research: Bcr 11(4): R46
Bulfoni, M.; Gerratana, L.; Del Ben, F.; Marzinotto, S.; Sorrentino, M.; Turetta, M.; Scoles, G.; Toffoletto, B.; Isola, M.; Beltrami, C.A.; Di Loreto, C.; Beltrami, A.P.; Puglisi, F.; Cesselli, D. 2016: In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis Breast Cancer Research: Bcr 18(1): 30
Li, M.; Zhang, B.; Zhang, Z.; Liu, X.; Qi, X.; Zhao, J.; Jiang, Y.; Zhai, H.; Ji, Y.; Luo, D. 2014: Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer Biomed Research International 2014: 981261
Yi-Wen, W.; Long-Long, L.; Ming, L.; Hao, L.; Kong-Wang, H. 2022: Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer Archives of Medical Science: Ams 18(5): 1297-1307
Pore, M.; Meijer, C.; de Bock, G.H.; Boersma-van Ek, W.; Terstappen, L.W.M.M.; Groen, H.J.M.; Timens, W.; Kruyt, F.A.E.; Hiltermann, T.J.N. 2016: Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer Clinical Lung Cancer 17(6): 535-542
Orrapin, S.; Udomruk, S.; Lapisatepun, W.; Moonmuang, S.; Phanphaisarn, A.; Phinyo, P.; Pruksakorn, D.; Chaiyawat, P. 2022: Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and their Perspective in HCC: a Systematic Review Cancers 14(14)
Manjunath, Y.; Upparahalli, S.V.; Avella, D.M.; Deroche, C.B.; Kimchi, E.T.; Staveley-O'Carroll, K.F.; Smith, C.J.; Li, G.; Kaifi, J.T. 2019: PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer Cancers 11(6)
Wang, Y.; Kim, T.Hyun.; Fouladdel, S.; Zhang, Z.; Soni, P.; Qin, A.; Zhao, L.; Azizi, E.; Lawrence, T.S.; Ramnath, N.; Cuneo, K.C.; Nagrath, S. 2019: PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer Scientific Reports 9(1): 566
Papadaki, M.A.; Kallergi, G.; Zafeiriou, Z.; Manouras, L.; Theodoropoulos, P.A.; Mavroudis, D.; Georgoulias, V.; Agelaki, S. 2014: Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer Bmc Cancer 14: 651
Wang, D.; Lu, P.; Zhang, H.; Luo, M.; Zhang, X.; Wei, X.; Gao, J.; Zhao, Z.; Liu, C. 2014: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients Oncotarget 5(21): 10803-10815
Zhang, L.; Wu, G.; Pantel, K. 2011: Detection of circulating tumor cells by RT-PCR significantly associated with poor prognosis in breast cancer Breast Cancer Research and Treatment 130(1): 359-364
Le Du, F.; Fujii, T.; Kida, K.; Davis, D.W.; Park, M.; Liu, D.D.; Wu, W.; Chavez-MacGregor, M.; Barcenas, C.H.; Valero, V.; Tripathy, D.; Reuben, J.M.; Ueno, N.T. 2020: EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy Plos one 15(3): E0229903
Fu, H.-C.; Chuang, I.-C.; Yang, Y.-C.; Chuang, P.-C.; Lin, H.; Ou, Y.-C.; Chang Chien, C.-C.; Huang, H.-S.; Kang, H.-Y. 2018: Low P16INK4A Expression Associated with High Expression of Cancer Stem Cell Markers Predicts Poor Prognosis in Cervical Cancer after Radiotherapy International Journal of Molecular Sciences 19(9)
Rack, B.; Bock, C.; Andergassen, U.; Doisneau-Sixou, S. 2012: Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients Histology and Histopathology 27(7): 855-864
Katoh, S.; Goi, T.; Naruse, T.; Ueda, Y.; Kurebayashi, H.; Nakazawa, T.; Kimura, Y.; Hirono, Y.; Yamaguchi, A. 2015: Cancer stem cell marker in circulating tumor cells: expression of CD44 variant exon 9 is strongly correlated to treatment refractoriness, recurrence and prognosis of human colorectal cancer Anticancer Research 35(1): 239-244